XLMM

IP属地:未知
    • XLMMXLMM
      ·2022-01-14
      That is some analysis!
      非常抱歉,此主贴已删除
      1,041评论
      举报
    • XLMMXLMM
      ·2022-01-12
      Go go go!
      非常抱歉,此主贴已删除
      7421
      举报
    • XLMMXLMM
      ·2022-01-12
      Awesome! 
      非常抱歉,此主贴已删除
      886评论
      举报
    • XLMMXLMM
      ·2022-01-11
      heavy discounts for the shares we love! 
      非常抱歉,此主贴已删除
      1,1771
      举报
    • XLMMXLMM
      ·2022-01-07
      Looks like Singapore is considering their vaccine too..
      非常抱歉,此主贴已删除
      798评论
      举报
    • XLMMXLMM
      ·2022-01-04
      Awesome! looks like several investment sites are starting to raise their price target for NVAX. 
      非常抱歉,此主贴已删除
      758评论
      举报
    • XLMMXLMM
      ·2022-01-01
      $Novavax(NVAX)$‌For those who are confused with the submisson of final data package and EUA application:31st Dec 2021: Chemistry, manufacturing and controls (CMC) data module submitted to U.S. Food and Drug Administration (FDA), completing final data packages required for emergency use authorization (EUA) application for Novavax' COVID-19 vaccine By 31st Jan 2022: UA application request to be submitted following one month required by FDA EUA guidancehttps://ir.novavax.com/2021-12-31-Novavax-Submits-Final-Data-Packages-to-U-S-FDA-as-Prerequisite-to-Emergency-Use-Authorization-Application-Request-for-COVID-19-Vaccine
      1,233评论
      举报
       
       
       
       

      热议股票